フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) and Eyetech Pharmaceuticals, Inc. (NASDAQ: EYET) today announced that the closing of the OSI acquisition...
Stockholders Overwhelmingly Approve Merger NEW YORK, Nov. 10 /PRNewswire-FirstCall/ -- Eyetech Pharmaceuticals, Inc. (NASDAQ:EYET) provided an...
Company achieves operating profitability, excluding certain charges, based on total revenue of $67.4 million and net product revenue of $55.5...
Phase 2 study of Macugen in diabetic macular edema (DME) published in the October issue of Ophthalmology NEW YORK, Oct. 17...
Retrospective, subgroup analyses of the VISION study suggest that treatment of early disease with Macugen may further reduce the risk of vision...
NEW YORK, Sept. 16 /PRNewswire-FirstCall/ -- Eyetech Pharmaceuticals, Inc. (NASDAQ:EYET) announced today that the Committee for Medicinal...
Acquisition Projected to be Accretive and Generate Combined 2006 Revenues of Over $600 Million MELVILLE, N.Y. and NEW YORK, Aug. 21...
OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) and Eyetech Pharmaceuticals, Inc. (NASDAQ: EYET) today announced that they have entered into a definitive...
Award recognizes Macugen's breakthrough technology as the first anti- angiogenic treatment approved in ophthalmology and the first aptamer therapy...
Eyetech Reports Second Quarter 2005 Financial Results - Gross Product Revenue for Macugen(R) (pegaptanib sodium injection) increased to $50...
Eyetech and Pfizer Comment on Data Presented at Meeting of Retinal Specialists NEW YORK, July 18 /PRNewswire-FirstCall/ -- Research presented...
Eyetech To Announce Second Quarter 2005 Financial Results On July 27, 2005 NEW YORK, July 15 /PRNewswire-FirstCall/ -- Eyetech Pharmaceuticals...
Eyetech Raises Full-Year Sales Forecast for Macugen(R) (pegaptanib sodium injection) Company shares research and development program to expand...
Eyetech Vision Day to Preview Future of Macugen Franchise Top Eyetech Executives and Ophthalmology Researchers to Present at Event This Wednesday...
Eyetech to Host Vision Day on Wednesday, June 22 Company to Comment On Macugen Launch and Research and Development Programs Aimed at Expanding the...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
サインアップして広告なしのエクスペリエンスを体験してください
今すぐ試してください
広告を残す